Literature DB >> 34140669

Sotorasib effective in KRAS-mutant NSCLC.

Peter Sidaway1.   

Abstract

Entities:  

Year:  2021        PMID： 34140669     DOI： 10.1038/s41571-021-00533-w

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Sotorasib for Lung Cancers with KRAS p.G12C Mutation.

Authors:  Ferdinandos Skoulidis; Bob T Li; Grace K Dy; Timothy J Price; Gerald S Falchook; Jürgen Wolf; Antoine Italiano; Martin Schuler; Hossein Borghaei; Fabrice Barlesi; Terufumi Kato; Alessandra Curioni-Fontecedro; Adrian Sacher; Alexander Spira; Suresh S Ramalingam; Toshiaki Takahashi; Benjamin Besse; Abraham Anderson; Agnes Ang; Qui Tran; Omar Mather; Haby Henary; Gataree Ngarmchamnanrith; Gregory Friberg; Vamsidhar Velcheti; Ramaswamy Govindan
Journal:  N Engl J Med       Date:  2021-06-04       Impact factor: 176.079
  1 in total
  1 in total

1.  Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments.

Authors:  Chiara Nicolazzo; Alain Gelibter; Irene Bottillo; Francesca Belardinilli; Simona Pisegna; Gianluigi De Renzi; Daniele Marinelli; Paola Grammatico; Enrico Cortesi; Giuseppe Giannini; Paola Gazzaniga
Journal:  Diagnostics (Basel)       Date:  2021-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.